GlassScriptPhysician profile
Jeremiah P Ladd
NPI 1760680011
$546.22
in general payments reported to CMS, 2019-2025
9 companies · $35.30 in 2025
The $35.30 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $324 · 2020: $38.46 · 2022: $7.17 · 2023: $45.39 · 2024: $95.42 · 2025: $35.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $176.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $190.50 | 2019-2025 | |
| Merz North America, INC. | $138.69 | 2019 | |
| Globus Medical, INC. | $53.99 | 2024 | Reline |
| Baxter Healthcare | $48.34 | 2019 | |
| Horizon Therapeutics Plc | $38.46 | 2020 | |
| Conetic Solutions, INC. | $28.63 | 2023 | |
| Heron Therapeutics, INC. | $21.81 | 2024 | Zynrelef |
| Vertex Pharmaceuticals Incorporated | $18.63 | 2025 | |
| Forte Bio-Pharma LLC | $7.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeremiah Ladd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.